Follow The Filings

CRSP position history

The shares of Crispr Therapeutics (CRSP) that HORIZON KINETICS ASSET MANAGEMENT LLC reported in each quarter’s 13F.

Equity, NAMEN AKT

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q3: 6,125 shares, $686K, 0.02% of portfolio
  2. 2021 Q4: 6,125 shares, $464K, 0.01% of portfolio
  3. 2022 Q1: 6,125 shares, $384K, <0.01% of portfolio
  4. 2022 Q2: 6,125 shares, $372K, <0.01% of portfolio
  5. 2022 Q3: 6,125 shares, $400K, <0.01% of portfolio
  6. 2022 Q4: 12,250 shares, $498K, <0.01% of portfolio, Add +100.0%
  7. 2023 Q1: 11,125 shares, $503K, <0.01% of portfolio, Reduce −9.2%
  8. 2023 Q2: 11,125 shares, $625K, 0.01% of portfolio
  9. 2023 Q3: 11,125 shares, $505K, <0.01% of portfolio
  10. 2023 Q4: 10,682 shares, $669K, 0.01% of portfolio, Reduce −4.0%
  11. 2024 Q1: 10,682 shares, $728K, 0.01% of portfolio
  12. 2024 Q2: 10,682 shares, $577K, 0.01% of portfolio
  13. 2024 Q3: 10,239 shares, $481K, <0.01% of portfolio, Reduce −4.1%
  14. 2024 Q4: 10,682 shares, $420K, <0.01% of portfolio, Add +4.3%
  15. 2025 Q1: 10,682 shares, $364K, <0.01% of portfolio
  16. 2025 Q2: 10,239 shares, $498K, <0.01% of portfolio, Reduce −4.1%
  17. 2025 Q3: 10,682 shares, $692K, <0.01% of portfolio, Add +4.3%
  18. 2025 Q4: 10,239 shares, $537K, <0.01% of portfolio, Reduce −4.1%
  19. 2026 Q1: 9,796 shares, $466K, <0.01% of portfolio, Reduce −4.3%
  20. 2026 Q2: 9,353 shares, $510K, <0.01% of portfolio, Reduce −4.5%
Holdings date Value % of holdings Shares Filing date All 13F holders